Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Fund raising through ....

Date: 30th July, 2026 The Deputy General Manager, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001. BSE Scrip Code: 542934 Sub: Prior intimation under Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2018. Dear Sir/ Madam, We wish to inform you that pursuant to Regulation 29(1)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors (“Board Meeting”) of Chandra Bhagat Pharma Limited (the "Company") is scheduled to be held on Wednesday 5th August, 2026, inter alia: 1. To Increasing in Authorised Share Capital of Company; 2. To consider a proposal of fund raising by issue of Equity Shares/ convertible warrants and/or any other instruments through Preferential allotment towards consideration for cash or other than cash, subject to approval of shareholders and compliances of applicable provision of law; 3. To fix the date, time, place for holding the Extra Ordinary General Meeting (“EOGM”) for obtaining shareholders’ approval for aforesaid preferential issue and other agenda items. 4. Any other business with the permission of the chair which is incidental and ancillary to the business. This is to, further, inform you, as intimated to the stock exchange, pursuant to the Code of Conduct for prevention of insider trading (the "Code of Conduct"), framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window for dealing in the securities shall remain closed for all connected persons / officers / designated employees / insiders, directors of the Company and immediate relatives of these persons, including but not limited to the persons specified in the Company's Code of Conduct from 30th July, 2026 till the end of 48 hours from the conclusion of the Board Meeting. Kindly take the same on record. Thank you FOR CHANDRA BHAGAT PHARMA LIMITED HEMANT C BHAGAT MANAGING DIRECTOR DIN: 00233530